Urgent.News

What's breaking now, across thousands of outlets.

Health & Medicine

UK lands £500M in biopharma pledges; Teva to shutter New Jersey site

Plus, news about Esteve and Regeneron. UK pulls in £500M investment: As part of the UK’s Autumn budget, Vertex Pharmaceuticals said it will invest over £300 million in a new R&D site in Oxford, UK ...

We haven't written up this one. Endpoints News has the full story — the link below goes straight to it.

Read the original at endpoints.news →

More in Health & Medicine

More from Thursday 29 October →